Sen. Max Baucus, D-Mont., and Rep. Dave Camp, R-Mich., have hit the road to call for tax reform, an effort the medtech industry has praised and sees as a possible avenue for overturning the 2.3% medical-device tax. "In the context of reforming the tax code to make U.S. business more competitive, repealing the medical-device excise tax that went into effect in January is a critical first step to protecting these jobs and ensuring a level playing field for Minnesota and the rest of the U.S. in the global economy," AdvaMed President and CEO Stephen Ubl said.

Related Summaries